Alzamend Neuro Inc. Gains 188.18%
Mon, Aug 19, 2024 at 07:34 PM
Alzamend Neuro Inc. (ALZN:NASDAQ) soared at $5.85, representing a gain of 188.2%. On Mon, Aug 19, 2024, ALZN:NASDAQ touched a New 2-Week High of $5.85. The stock got featured on our News Catalysts scanner on Mon, Aug 19, 2024 at 10:16 AM in the 'PATNERSHIP' category. From Mon, Aug 05, 2024, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Aug 19, 2024 at $15.06 with a volume of 81M+.
About Alzamend Neuro Inc. (ALZN:NASDAQ)
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.
Top 10 Gainers:
- Alzamend Neuro Inc. (ALZN:NASDAQ), 188.18%
- NuCana plc (NCNA:NASDAQ), 181.16%
- Unico American Corporation (UNAM:NASDAQ), 150%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 141.78%
- Sonder Holdings Inc. (SOND:NASDAQ), 130.53%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 128.64%
- SRAX, Inc. (SRAX:NASDAQ), 56%
- Telomir Pharmaceuticals Inc. (TELO:NASDAQ), 52.88%
- Electra Battery Materials Corporation (ELBM:NASDAQ), 50.24%
- Maxeon Solar Technologies Ltd. (MAXN:NASDAQ), 46.17%